{"disease":{"id":"potentially-malignant-lesions","name":"potentially malignant lesions"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06219330","title":"Cathelicidin LL-37 Relation to Potentially Malignant Lesions","phase":"","overall_status":"COMPLETED","enrollment_count":45,"lead_sponsor_name":"Fayoum University","has_results":false},{"nct_id":"NCT05730855","title":"Diagnostic Accuracy of lncRNA DQ786243 and miRNA146a in Saliva of Oral Potentially Malignant Lesions","phase":"","overall_status":"COMPLETED","enrollment_count":45,"lead_sponsor_name":"Fayoum University","has_results":false},{"nct_id":"NCT06271564","title":"Effectiveness of Topical Magnetite Zinc Oxide Composite Nanoparticles in the Management of Oral Potentially Malignant Lesions","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"Ain Shams University","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}